Study of the secretion of substance P, neurotensin and somatostatin in patients with cholelithiasis

Revista Espanola de Enfermedades Digestivas

Volumn 89, Issue 6, 1997, Pages 430-434

  Ortega Lopez D ^a   Martinez Sarmiento J ^a   Barque, M ^a   Sobrino, J A ^a   Fernandez D ^a   Calderon T ^a   Montes, E ^a   De Pablos, I ^a   Coca, E ^a   Mallen A ^a   Mayol, J ^a   Alvarez Fernandez Represa J ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Biliary lithiasis; Cholelithiasis; Digestive peptides; Gastrointestinal hormones; Neurotensin; Somatostatin; Substance P

Indexed keywords

NEUROTENSIN; SOMATOSTATIN; SUBSTANCE P;

ADULT; ARTICLE; CASE CONTROL STUDY; CHOLELITHIASIS; CLINICAL TRIAL; FEMALE; HUMAN; MALE; METABOLISM;

ADULT; CASE-CONTROL STUDIES; CHOLELITHIASIS; FEMALE; HUMANS; MALE; NEUROTENSIN; SOMATOSTATIN; SUBSTANCE P;

EID: 84865944563     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Carey MC. Pathogenesis of gallstones Am J Surg 1993;165:410-9.
2. O'Donnell LJD, Fairclough PD. Gallstones and gallbladder motility. Gut 1993;34:440-3.
3. Mate L, Sakamoto T, Greeley GH Jr, Thompson JC. Effect of substance P on contractions of the gallbladder. Surg Gynecol Obstet 1986;163(2):163-6.
4. Rosell S, Bjorkroth U, Chang D, Yamaguch I, Wan YP, Rackur G, Fisher G, Folkers K. Effects of substance P and analogs on isolated guinea-pig ileum. In: Substance P. Edits. Von Euler US, Pernow B. New York. Raven Press, 1977:83-8.
5. Walker JP, Khalil T, Wiener I, Fagan CJ, Townsend CM Jr, Greeley GH Jr, Thompson JC. The role of neurotensin in human gallbladder motility. Ann Surg 1985;201:678-83.
6. Schlegel W, Raptis S, Harvey RR Oliver JM, Pfeiffer EF. Inhibition of cholecystokinin-pancreozymin release by somatostatin. The Lancet 1977;2(8030):166-8.
7. Fisher RS. Rock E. Levin G, Malmud L. Effects of somatostatin on gallbladder emptying. Gastroenterology 1987;92:885-90.
8. Dwenger A. Radioimmunoassay: an overview. J Clin Biochem 1984;22:883.
9. Shulkes A, Chick P, Wong H, Walsh JH. A radioimmunoassay for neurotensin in human plasma. Clin Chim Acta 1982;125:49.
10. Peelers TH, Depraetere Y, Vantrappen G. Simple extraction method and RIA for somatostatin in human plasma. Clin Chem 1981;27:888-91.
11. Akande B, Reilly P, Modlin IM, Jaffe BM. Radioimmunoassay measurement of substance P release following a meat meal. Surgery 1981;89(3):378-83.
12. Meldrum LA, Bojarski JC, Calam J. Effects of substance P and other neuropeptides on guinea pig gallbladder muscle. Digestion 1987;37:193-9.
13. Guo YS, Singh P, Lluis F, Gomez G, Thompson JC. Contractile response of gallbladder and sphincter of Oddi to substance P and related peptides in vitro compared to CCK-8. [Abstract]. Fed Proc 1986;45:291.
14. Guo YS, Singh P, Upp Jr JR, Thompson JC. Species-specific effects of neurotensin on gallbladder contraction in vitro. Dig Dis Sci 1989;34(1):21-6.
15. Sakamoto T, Mate L, Greeley Jr GH, Townsend Jr CM. Thompson JC. Effect of neurotensin on gallbladder contraction in dogs. [Abstract]. Gastroenterology 1984;86:1229.
16. Fujimura M, Sakamoto T, Khalil T, Greeley GH Jr, Town-send CM Jr, Thompson JC. Physiologic role of neurotensin in gallbladder contraction in the dog. Surg Forum 1984;35: 192-4.
17. Buscail LE, Puel-Bousquet C, Harris AG, Tauber JP. Effects of biliary lithogenesis in acromegalic patients with long-term octreotide (SMS 201-995) treatment. Gastroenterol Clin Biol 1991;15:800-4.
18. Ewins DL, Javaid A, Coskeran PB, Shah S, Butler J. Deprez PH, Miell J, Calam J, Barrett JJ, Dawson JM. Assessment of gallbladder dynamics, cholecystokinin release and the development of gallstones during octreotide therapy for acromegaly. Q J Med 1992;83(300):295-306.
19. Magnusson I, Einarsson K, Angelin B, Nyberg B, Bergström K, Thulin L. Effects of somatostatin on hepatic bile formation. Gastroenterology 1989;96(I):206-12.